| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41409-018-0265-7 |
| P698 | PubMed publication ID | 29988063 |
| P50 | author | Jason Tay | Q57062676 |
| P2093 | author name string | D Stewart | |
| J Storek | |||
| A Daly | |||
| L Savoie | |||
| S Beattie | |||
| K Jamani | |||
| L Labelle | |||
| P2860 | cites work | Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging | Q24646862 |
| Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Q24685958 | ||
| Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies | Q27487855 | ||
| Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation | Q30274960 | ||
| Older patients with myeloma derive similar benefit from autologous transplantation. | Q30370038 | ||
| Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome | Q33813439 | ||
| A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia | Q33829105 | ||
| Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis | Q33905984 | ||
| Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. | Q33978945 | ||
| The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus | Q34210217 | ||
| Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation | Q34249446 | ||
| The hematopoietic stem cell transplant comorbidity index can predict for 30-day readmission following autologous stem cell transplant for lymphoma and multiple myeloma | Q34315831 | ||
| Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age. | Q34432415 | ||
| Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates | Q34514273 | ||
| The influence of social support on hematopoietic stem cell transplantation survival: a systematic review of literature | Q34700451 | ||
| Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation | Q34700473 | ||
| Mismanaging the gift of life: noncompliance in the context of adult stem cell transplantation | Q34702387 | ||
| Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients | Q35017347 | ||
| Baseline body mass index among children and adults undergoing allogeneic hematopoietic cell transplantation: clinical characteristics and outcomes. | Q35152208 | ||
| Reevaluation of the pretransplant assessment of mortality score after allogeneic hematopoietic transplantation | Q35533458 | ||
| Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies | Q35554703 | ||
| Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation. | Q35745142 | ||
| Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done? | Q35843555 | ||
| A common variant of the p16(INK4a) genetic region is associated with physical function in older people | Q36136695 | ||
| Is It Better to Be Rich or Relaxed? Sociobiology Meets Bone Marrow Transplant | Q36794271 | ||
| Cardiac assessment of patients for haematopoietic stem cell transplantation | Q36797768 | ||
| A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD). | Q37142757 | ||
| Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? | Q37177449 | ||
| Patients at risk: addressing addiction in patients undergoing hematopoietic SCT. | Q37222245 | ||
| Performance Status and Comorbidity Predict Transplant-Related Mortality After Allogeneic Hematopoietic Cell Transplantation | Q59315420 | ||
| Senior adult oncology, version 2.2014: clinical practice guidelines in oncology | Q60152831 | ||
| Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma | Q60218172 | ||
| Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997 | Q74460243 | ||
| Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years | Q74502702 | ||
| Patient socioeconomic status as a prognostic factor for allo-SCT | Q79773955 | ||
| Predictive value of QT dispersion for acute heart failure after autologous and allogeneic hematopoietic stem cell transplantation | Q80011033 | ||
| Morbidity and mortality following bone marrow transplantation: predictive utility of pre-BMT affective functioning, compliance, and social support stability | Q81405239 | ||
| Value of pretransplant pulmonary function tests in predicting pulmonary complications after autologous peripheral stem cell transplantation | Q81477924 | ||
| Allogeneic hematopoietic stem-cell transplantation for patients 50 years or older with myelodysplastic syndromes or secondary acute myeloid leukemia | Q82236404 | ||
| Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians | Q82599031 | ||
| A risk score for mortality after allogeneic hematopoietic cell transplantation | Q82892217 | ||
| Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT | Q83482859 | ||
| Autologous stem cell transplant is feasible in very elderly patients with lymphoma and limited comorbidity | Q83518087 | ||
| Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice | Q83761851 | ||
| Role of HCT-comorbidity index, age and disease status at transplantation in predicting survival and non-relapse mortality in patients with myelodysplasia and leukemia undergoing reduced-intensity-conditioning hemopoeitic progenitor cell transplantat | Q84533304 | ||
| Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation | Q84590495 | ||
| Predictive value of risk assessment scores in patients with hematologic malignancies undergoing reduced-intensity conditioning allogeneic stem cell transplantation | Q87915040 | ||
| Hematopoietic cell transplant comorbidity index is predictive of survival after autologous hematopoietic cell transplantation in multiple myeloma | Q37651875 | ||
| How we approach patient evaluation for hematopoietic stem cell transplantation | Q37755957 | ||
| The EBMT risk score | Q37885167 | ||
| The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach | Q38040708 | ||
| An introduction to patient decision aids | Q38123788 | ||
| The relevance of a geriatric assessment for elderly patients with a haematological malignancy--a systematic review | Q38179573 | ||
| Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. | Q38463036 | ||
| Psychological interventions for distress in adults undergoing haematopoietic stem cell transplantation: a systematic review with meta-analysis | Q38561974 | ||
| Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force | Q38791805 | ||
| Patient-Reported Outcomes and Socioeconomic Status as Predictors of Clinical Outcomes after Hematopoietic Stem Cell Transplantation: A Study from the Blood and Marrow Transplant Clinical Trials Network 0902 Trial | Q38827434 | ||
| Pre-transplant emotional support is associated with longer survival after allogeneic hematopoietic stem cell transplantation | Q38840768 | ||
| Aging: Treating the Older Patient | Q39013605 | ||
| Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT). | Q39309946 | ||
| Impact of psychological screening on routine outpatient care of hematopoietic cell transplantation survivors | Q39376991 | ||
| Association of Nutritional Parameters with Clinical Outcomes in Patients with Acute Myeloid Leukemia Undergoing Haematopoietic Stem Cell Transplantation | Q39378689 | ||
| Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival | Q39763521 | ||
| Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. | Q39904388 | ||
| Is perceived social support a predictor of survival for patients undergoing autologous peripheral blood stem cell transplantation? | Q40441197 | ||
| Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation. | Q40718203 | ||
| Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients | Q40721259 | ||
| Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2. | Q41592261 | ||
| High-dose chemotherapy with carmustine, etoposide, cytarabine and melphalan followed by autologous stem cell transplant is an effective treatment for elderly patients with poor-prognosis lymphoma | Q41618393 | ||
| High-dose chemotherapy with autologous stem cell transplantation for elderly patients with relapsed/refractory diffuse large B cell lymphoma: a nationwide retrospective study | Q42229931 | ||
| The addition of 400 cGY total body irradiation to a regimen incorporating once-daily intravenous busulfan, fludarabine, and antithymocyte globulin reduces relapse without affecting nonrelapse mortality in acute myelogenous leukemia | Q43233553 | ||
| A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation | Q44035534 | ||
| Predicting chemotherapy toxicity in older adults and the importance of geriatric assessment | Q44147349 | ||
| Allogeneic hematopoietic stem cell transplantation for patients with mildly reduced renal function as defined based on creatinine clearance before transplantation | Q44472298 | ||
| Predictors of 1-year survival assessed at the time of bone marrow transplantation | Q45042788 | ||
| Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. | Q45933706 | ||
| The significant impact of acute kidney injury on CKD in patients who survived over 10 years after myeloablative allogeneic SCT. | Q46689958 | ||
| Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation | Q46724769 | ||
| Outcomes after autologous SCT in lymphoma patients grouped by weight | Q47406671 | ||
| Depression and anxiety following hematopoietic stem cell transplantation: a prospective population-based study in Germany | Q47772311 | ||
| Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment? | Q47869630 | ||
| Predictors of non-compliance in autologous hematopoietic SCT patients undergoing out-patient transplants | Q48846109 | ||
| Balancing give and take between patients and their spousal caregivers in hematopoietic stem cell transplantation | Q48905859 | ||
| Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis | Q50058648 | ||
| Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force | Q50205301 | ||
| Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy | Q50465475 | ||
| The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation. | Q50863410 | ||
| Substance abuse and bone marrow transplant. | Q51543855 | ||
| Allogeneic BMT and patient eligibility based on psychosocial criteria: a survey of BMT professionals. | Q52288444 | ||
| Ethical reasoning about patient eligibility in allogeneic BMT based on psychosocial criteria. | Q52294408 | ||
| Dental treatment prior to stem cell transplantation and its influence on the posttransplantation outcome. | Q52951363 | ||
| Autologous stem cell transplantation in patients of 70 years and older with multiple myeloma: Results from a matched pair analysis. | Q53481866 | ||
| Usefulness of liver stiffness measurement in predicting hepatic veno-occlusive disease development in patients who undergo HSCT | Q56960980 | ||
| P433 | issue | 3 | |
| P921 | main subject | stem cell transplantation | Q65592366 |
| P304 | page(s) | 368-382 | |
| P577 | publication date | 2018-07-09 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Patient eligibility for hematopoietic stem cell transplantation: a review of patient-associated variables | |
| P478 | volume | 54 |
Search more.